Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide for Cabazitaxel-Induced Diarrhea in CRPC
NCT01469338Phase 2Terminated
- Sponsor
- University of Southern California
- Start
- Jul 2012
- Primary completion
- Oct 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of Octreotide long-acting injection in diarrhea, sponsored by University of Southern California. Started Jul 2012; status: terminated.
02
Drugs
Octreotide long-acting injection
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT01469338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01469338.